Law360
10 Global Challenges For Life Sciences Cos. In 2016
January 27, 2016
Life sciences companies face many challenges for 2016, including the demand to develop innovative products at reduced cost. More and more, this means that companies must assess opportunities in major markets across the globe and seek value-maximizing partnerships at all phases of the product life cycle, from development to manufacturing to marketing. The increasingly global and increasingly interconnected nature of the life sciences industry also means that companies must track litigation, policy, regulatory and enforcement developments in the U.S., EU, Asia and other major markets, and must also anticipate the ways in which these developments will impact business opportunities.
Contacts
Capabilities
Suggested News & Insights
Sidley Sponsors the 2026 EU Pharma Law ForumTuesday, May 19, 2026 – Thursday, May 21, 2026Women's Life Sciences Network: EU Pharmaceutical Law ForumTuesday, May 19, 2026Inside Strategic Partnerships: Clinical Trial Considerations and AI/Digital Health InsightsThursday, March 12, 2026Sidley Wins a Trio of Awards at the 2026 Benchmark Litigation US AwardsMarch 12, 2026New U.S. FDA Letter Contradicts Decades-Old Precedent on Prescription Drug PromotionMarch 10, 2026New U.S. DOJ Antitrust Leadership Signals More Criminal Prosecutions and Longer Prison SentencesMarch 6, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory


